neural
tube
defect
ntd
common
birth
defect
whose
specif
biomark
need
purpos
pilot
studi
determin
whether
protein
profil
ntdmother
differ
normal
control
use
selditofm
proteinchip
biomark
system
use
evalu
matern
serum
sampl
urin
sampl
amniot
fluid
sampl
valid
classif
tree
challeng
blind
test
set
includ
anoth
ntdmother
control
serum
sampl
anoth
ntdmother
control
urin
sampl
anoth
ntdmother
control
amniot
fluid
sampl
eight
protein
detect
serum
sampl
upregul
four
protein
downregul
ntd
group
four
protein
detect
urin
sampl
upregul
one
protein
downregul
ntd
group
six
protein
detect
amniot
fluid
sampl
upregul
one
protein
downregul
ntd
group
classif
tree
serum
sampl
separ
ntd
healthi
individu
achiev
sensit
specif
train
set
achiev
sensit
specif
posit
predict
valu
test
set
classif
tree
urin
sampl
separ
ntd
control
achiev
sensit
specif
train
set
achiev
sensit
specif
posit
predict
valu
test
set
classif
tree
amniot
fluid
sampl
separ
ntd
control
achiev
sensit
specif
train
set
achiev
sensit
specif
posit
predict
valu
test
set
suggest
selditofm
addit
method
ntd
pregnanc
detect
preval
neural
tube
defect
ntd
known
vari
significantli
base
upon
geographi
ethnic
rang
newborn
mother
ntdaffect
child
like
give
birth
second
child
ntd
suggest
involv
environment
genet
factor
etiolog
multipl
type
isol
ntd
includ
spina
bifida
anencephali
current
prenat
screen
effort
base
two
complementari
method
matern
serum
alphafetoprotein
msafp
ultrasound
screen
determin
fetu
ntd
expos
membran
allow
afp
leak
amniot
fluid
matern
serum
level
roughli
proport
size
expos
area
howev
level
msafp
specif
indic
ntd
sinc
also
increas
ventral
wall
defect
omphalocel
gastroschisi
abnorm
glomerular
diseas
nephrot
syndrom
defect
placent
membran
fetal
hydrop
fetal
blood
contamin
due
traumat
amniocentesi
well
pregnancyrel
problem
although
matter
controversi
spina
bifida
lesion
cover
healthi
skin
msafp
amniot
fluid
afp
afafp
concentr
gener
found
normal
therefor
due
low
specif
msafp
afafp
level
use
screen
tool
limit
diagnost
valu
norem
cowork
found
among
ntd
case
receiv
msafp
test
case
neg
matern
serum
screen
result
includ
spina
bifida
case
test
encephalocel
case
test
anencephali
case
present
appear
specif
marker
ntd
identifi
matern
serum
kooper
et
al
found
pregnanc
without
increas
ntd
risk
afafp
level
mom
multipl
median
two
associ
ntd
two
pregnanc
increas
ntd
risk
elev
afafp
level
associ
affect
pregnanc
pregnanc
clinic
diagnos
fetal
ntd
increas
afafp
level
biochem
diagnosi
ntd
base
electrophoresi
amniot
fluid
cholinesteras
cholinesteras
includ
butyrylcholinesteras
normal
present
serum
amniot
fluid
acetylcholinesteras
specif
neural
tissu
normal
absent
amniot
fluid
fetu
ntd
acetylcholinesteras
present
rapidlymigr
eletrophoret
band
addit
butyrylcholinesteras
howev
amniocentesi
invas
procedur
use
routin
clinic
practic
surfaceenhanc
laser
desorptionion
timeofflight
mass
spectrometri
selditofm
breakthrough
clinic
proteom
detect
differ
protein
express
pattern
bodi
fluid
tissu
specimen
patient
healthi
subject
rapid
develop
provid
altern
tool
search
biomark
selditofm
detect
protein
select
adsorb
onto
surfac
protein
chip
array
nonspecif
bound
protein
wash
stringent
buffer
shown
sensit
rapid
reliabl
techniqu
success
appli
discoveri
serum
biomark
mani
cancer
nervou
system
diseas
renal
diseas
furthermor
construct
classif
tree
use
artifici
intellig
algorithm
process
seldi
data
improv
accuraci
differenti
cancer
patient
noncanc
group
hypothesi
protein
express
profil
ntd
may
consid
potenti
diagnost
approach
use
selditofm
purpos
pilot
studi
preliminarili
explor
differenti
protein
express
pattern
ntd
case
mother
normal
control
mother
use
selditofm
protein
profil
classif
regress
tree
cart
analysi
order
differenti
pregnanc
complic
presenc
ntdaffect
fetu
healthi
control
experiment
protocol
approv
china
medic
univers
institut
review
board
written
inform
consent
obtain
mother
ntdaffect
fetus
healthi
volunt
studi
matern
serum
sampl
mother
ntdaffect
fetus
normal
control
mother
matern
urin
sampl
mother
ntdaffect
fetus
normal
control
mother
matern
amniot
fluid
sampl
mother
ntdaffect
fetus
normal
control
mother
collect
gestat
week
gestat
age
determin
date
last
menstrual
period
lmp
ultrasonographi
examin
lmp
uncertain
healthi
volunt
receiv
prenat
medic
examin
shengj
hospit
recruit
control
group
normal
control
mother
pregnancyrel
problem
diabet
hypertens
carri
fetus
lack
congenit
defect
normal
control
mother
normal
biochemistri
detect
serum
urin
control
amniot
fluid
sampl
collect
pregnant
women
normal
fetal
karyotyp
karyotyp
fetus
evalu
follow
amniocentesi
prenat
diagnos
ntdaffect
normal
fetus
confirm
use
ultrasonographi
ntd
studi
classifi
two
differ
clinic
type
spina
bifida
anencephali
two
ml
whole
blood
collect
morn
fast
overnight
store
hour
blood
sampl
centrifug
rpm
min
ml
aliquot
store
analyz
two
ml
urin
collect
morn
fast
overnight
urin
immedi
centrifug
rpm
min
ml
aliquot
store
analyz
amniot
fluid
obtain
mother
carri
ntd
fetus
transabdomin
amniocentesi
induc
labor
mother
suspect
fetu
trisomi
ultim
confirm
normal
karyotyp
prenat
examin
amniot
fluid
sampl
collect
asept
procedur
abdomin
wall
direct
ultrasound
guidanc
use
punctur
needl
two
ml
amniot
fluid
collect
immedi
centrifug
rpm
min
distribut
ml
aliquot
store
analyz
efficaci
strong
anion
exchang
weak
cation
exchang
wcx
protein
chip
ciphergen
biosystem
inc
fremont
ca
usa
serum
protein
profil
test
studi
result
show
weak
cation
exchang
proteinchip
higher
captur
abil
signaltonois
ratio
sn
therefor
select
subsequ
experi
bind
protein
proteinchip
array
also
affect
ph
depend
buffer
chang
ionic
strength
buffer
serum
urin
amniot
fluid
sampl
thaw
ice
centrifug
rpm
min
time
ml
buffer
moll
urea
dimethylammonio
propanesulfon
mmoll
trishcl
ph
dithiothreitol
ad
ml
supernat
vortex
min
point
ml
bind
buffer
mmoll
naac
ph
ad
serum
sampl
ml
bind
buffer
ad
urin
sampl
ml
bind
buffer
figur
seldi
profil
show
peak
averag
mass
da
upregul
ntd
compar
control
serum
serum
mass
spectra
mother
ntdaffect
fetus
compar
control
mother
masstochang
ratio
mz
rang
da
xaxi
show
molecular
weight
peak
yaxi
show
intens
peak
figur
seldi
profil
show
peak
averag
mass
da
downregul
ntd
compar
control
serum
serum
mass
spectra
mother
ntdaffect
fetus
compar
control
mother
masstochang
ratio
mz
rang
da
xaxi
show
molecular
weight
peak
yaxi
show
intens
peak
ad
amniot
fluid
sampl
immedi
mix
equilibr
chip
ml
bind
buffer
appli
chip
spot
shake
rpm
min
excess
buffer
remov
without
contact
activ
surfac
procedur
repeat
ml
prepar
serum
sampl
urin
sampl
amniot
fluid
sampl
ad
bioprocessor
well
chip
incub
humid
chamber
h
shake
rpm
room
temperatur
excess
buffer
remov
ml
bind
buffer
ad
well
shake
room
temperatur
min
procedur
repeat
spot
wash
ml
deioniz
water
ml
satur
sinnapin
acid
appli
spot
chip
allow
air
dri
chip
reincub
sinnapin
acid
air
dri
captur
protein
array
detect
pbsii
c
reader
ciphergen
biosystem
accuraci
mass
spectrum
calibr
use
allinon
peptid
molecular
mass
standard
ciphergen
biosystem
inc
fremont
ca
usa
day
experi
high
cutoff
molecular
weight
set
dalton
da
optim
rang
da
laser
intens
detect
sensit
sampl
activ
time
error
rang
molecular
weight
control
intrachip
interchip
qualiti
control
includ
coeffici
variat
cv
control
peak
amplitud
spectra
analyz
use
biomark
wizard
softwar
ciphergen
biosystem
inc
qualifi
mass
peak
sn
mz
da
detect
automat
major
resolv
proteinpeptid
within
rang
molecular
mass
da
exclud
analysi
sinc
mainli
nois
energyabsorb
molecul
eam
peak
intens
normal
total
ionic
current
peak
mz
da
use
proteinchip
softwar
version
ciphergen
biosystem
inc
valid
experi
protein
peak
present
sampl
deviat
peak
amplitud
smaller
sampl
paramet
protein
peak
present
mean
valu
plu
minu
standard
deviat
spectral
data
train
set
analyz
use
biomark
pattern
softwar
bp
version
ciphergen
biosystem
establish
classif
tree
classif
regress
tree
cart
analysi
decis
tree
classif
pattern
gener
use
bp
version
statist
tool
develop
breiman
et
al
implement
cart
bp
use
peak
inform
gener
sampl
train
set
build
classif
tree
cart
consist
tree
construct
tree
prune
tree
construct
process
primarili
split
spectral
data
train
set
two
node
questionnair
criteria
split
decis
base
intens
peak
answer
mass
intens
less
equal
x
split
data
set
two
node
left
node
ye
right
node
split
process
repeat
gain
classif
termin
node
reach
classif
termin
node
base
clinic
group
sampl
ie
ntd
control
repres
major
sampl
node
tree
prune
step
classif
tree
cut
desir
size
use
treecost
complex
prune
calcul
sensit
specif
posit
predict
valu
neg
predict
valu
perform
use
bp
version
ciphergen
biosystem
inc
comparison
paramet
ntd
group
control
group
perform
use
ttest
consid
statist
signific
total
qualifi
mass
peak
sn
detect
seldi
particularli
effect
resolv
low
molecular
weight
kda
protein
polypeptid
intens
mass
peak
ntd
group
control
group
significantli
differ
among
protein
mz
fig
da
upregul
peak
mz
fig
downregul
ntd
group
compar
normal
control
group
tabl
total
qualifi
mass
peak
sn
detect
intens
mass
peak
significantli
differ
ntd
group
normal
control
group
among
protein
mz
fig
da
upregul
peak
mz
da
downregul
ntd
group
compar
control
group
tabl
total
qualifi
mass
peak
sn
detect
mass
peak
ntd
group
significantli
differ
intens
normal
control
group
among
protein
mz
fig
da
upregul
peak
mz
da
downregul
ntd
group
compar
control
group
tabl
singl
peak
identifi
alon
indic
peak
could
complet
differenti
ntd
group
normal
control
group
serum
urin
amniot
fluid
sampl
respect
decis
tree
classif
algorithm
built
use
protein
peak
protein
peak
da
automat
select
splitter
da
peak
use
root
node
classif
tree
split
sampl
two
group
fig
left
node
termin
node
includ
peak
intens
right
node
node
contain
remain
peak
intens
branch
node
classifi
next
layer
use
method
da
cutoff
final
sampl
classifi
termin
node
classif
tree
obtain
fig
pattern
analysi
process
yield
sensit
specif
posit
predict
valu
neg
predict
valu
train
set
tabl
valid
accuraci
classif
tree
algorithm
evalu
challeng
classifi
blind
object
correctli
test
set
consist
sampl
serum
mother
ntdaffect
fetus
analysi
urin
sampl
mother
ntdaffect
fetus
normal
control
mother
reveal
two
major
differenti
express
protein
da
use
classif
figur
seldi
profil
show
peak
averag
mass
da
upregul
ntd
compar
control
urin
urin
mass
spectra
mother
ntdaffect
fetus
compar
control
mother
masstochang
ratio
mz
rang
da
xaxi
show
molecular
weight
peak
yaxi
show
intens
peak
figur
seldi
profil
show
peak
averag
mass
da
upregul
ntd
compar
control
amniot
fluid
amniot
fluid
mass
spectra
mother
ntdaffect
fetus
compar
control
mother
masstochang
ratio
mz
rang
da
xaxi
show
molecular
weight
peak
yaxi
show
intens
peak
pattern
gener
termin
node
fig
result
yield
sensit
specif
posit
predict
valu
neg
predict
valu
tabl
valid
classif
tree
challeng
blind
test
set
includ
anoth
sampl
urin
mother
ntdaffect
fetus
sampl
urin
healthi
control
algorithm
correctli
classifi
analysi
amniot
fluid
sampl
mother
ntdaffect
fetus
normal
control
mother
reveal
two
major
differenti
express
protein
da
use
classif
pattern
gener
termin
node
fig
result
yield
sensit
specif
posit
predict
valu
neg
predict
valu
tabl
compar
among
serum
urin
amniot
fluid
seldi
profil
four
differenti
express
mass
mz
da
coexist
serum
urin
amniot
fluid
tabl
msafp
afafp
amniot
fluid
cholinesteras
primari
protein
biomark
use
prenat
diagnosi
ntd
msafp
screen
ultrasonographi
use
prenat
detect
ntdaffect
fetus
although
american
colleg
obstetrician
gynecologist
recommend
pregnant
women
offer
msafp
screen
second
trimest
pregnanc
detect
rate
ntd
use
elev
msafp
level
screen
tool
caus
elev
msafp
level
ntd
includ
underestim
gestat
age
congenit
skin
defect
pilonid
cyst
abdomin
wall
defect
gastrointestin
defect
obstruct
liver
necrosi
cloacal
exstrophi
cystic
hygroma
sacrococcyg
teratoma
renal
anomali
urinari
obstruct
polycyst
kidney
absent
kidney
congenit
nephrosi
osteogenesi
imperfecta
low
birth
weight
oligohydramnio
multipl
gestat
matern
underweight
szajkowski
et
al
suggest
msafp
screen
low
sensit
fetal
hydrocephalu
rare
elev
isol
case
screen
ntd
routin
prenat
test
mainli
due
associ
secondtrimest
matern
serum
screen
syndrom
determin
combin
low
afp
valu
high
hcg
valu
afafp
also
use
indic
ntd
specif
satisfactori
sensit
therefor
suggest
perform
routin
afafp
test
earli
secondtrimest
genet
amniocentesi
widlund
et
al
rule
possibl
open
fetal
ntd
seem
justifi
given
limit
clinic
diagnost
valu
electrophoresi
amniot
fluid
cholinesteras
also
use
biochem
diagnos
ntd
good
sensit
specif
posit
predict
valu
neg
predict
valu
howev
invas
techniqu
amniocentesi
might
caus
abort
infect
injuri
mother
fetu
must
weigh
valu
perform
test
proteom
analysi
provid
uniqu
tool
identif
diagnost
biomark
evalu
diseas
progress
develop
drug
selditofm
use
resolv
protein
biolog
specimen
bind
biochem
distinct
proteinchip
mani
advantag
compar
tradit
approach
much
faster
perform
highthroughput
capabl
requir
small
amount
protein
sampl
rel
high
sensit
detect
protein
picomol
attamol
rang
effect
resolv
low
mass
protein
kda
directli
applic
develop
clinic
assay
sinc
ntd
multifactori
trait
like
combin
sever
biomark
becom
signatur
necessari
effect
differenti
ntd
control
combin
peak
da
serum
sampl
peak
da
urin
sampl
peak
da
amniot
fluid
sampl
studi
profil
multipl
protein
perform
use
seldi
technolog
biomark
pattern
softwar
use
analyz
larg
volum
gener
data
proteinspeptid
deriv
fetu
mother
could
use
classif
system
produc
rel
accur
diagnosi
biomark
detect
seldi
accur
select
classifi
result
confirm
suitabl
selditofm
protein
profil
serum
urin
amniot
fluid
sampl
yield
rel
high
sensit
specif
diagnosi
ntd
greater
number
differ
protein
serum
sampl
amniot
fluid
sampl
amniot
fluid
directli
measur
fetal
protein
matern
serum
howev
analyz
data
found
four
proteinpeptid
biomark
da
detect
serum
urin
amniot
fluid
sampl
one
possibl
explan
four
proteinpeptid
biomark
might
relat
abnorm
protein
express
ntd
sinc
identif
biomark
essenti
understand
biolog
role
ntd
current
make
effort
character
proteinpeptid
biomark
ultim
clinic
applic
protein
profil
earli
detect
ntd
matern
bodi
fluid
serum
urin
detect
larger
number
peak
serum
sampl
urin
amniot
fluid
sampl
suggest
identif
candid
biomark
matern
serum
sampl
may
product
note
differenti
express
protein
peak
use
cart
analysi
wadsworth
et
al
suggest
cart
analysi
examin
possibl
protein
peak
combin
input
spectral
data
gener
best
classif
tree
statist
insignific
protein
peak
includ
also
import
classif
algorithm
stratif
although
peak
da
shown
figur
statist
differ
two
group
serum
crucial
classif
tree
delin
subset
group
stratifi
signific
peak
da
use
peak
da
urin
sampl
cart
shown
figur
similar
peak
da
serum
sampl
cart
accord
literatur
anoth
research
group
use
twodimension
gel
electrophoresi
mass
spectrometri
ms
character
differenti
express
protein
amnioticfluid
sampl
afss
embryon
day
e
rat
fetus
spina
bifida
aperta
induc
retino
acid
ra
identifi
five
protein
differenti
express
afss
spina
bifida
aperta
includ
three
upregul
protein
transferrin
antiproteinas
signal
recognit
particl
receptor
b
subunit
srprb
kda
two
downregul
protein
specif
found
fetoprotein
afp
fragment
downregul
afp
fragment
upregul
afss
embryo
spina
bifida
aperta
compar
proteom
studi
afss
rat
fetus
spina
bifida
aperta
may
provid
new
insight
neural
tube
defect
contribut
prenat
screen
studi
suggest
ntdsspecif
proteom
signatur
like
present
serum
urin
amniot
fluid
mother
carri
ntd
fetu
report
present
although
afp
screen
detect
affect
fetus
fals
posit
rate
second
trimest
ultrasound
specif
sensit
ntd
week
current
still
controversi
whether
suffici
reli
ultrasound
detect
ntd
recent
literatur
even
suggest
ultrasound
use
new
techniqu
ultrasound
high
specif
sensit
paper
recommend
abolish
msap
reli
ultrasound
approach
specif
sensit
howev
hand
recent
studi
also
demonstr
limit
ultrasound
approach
alon
detect
ntd
exampl
one
studi
show
ultrasound
bipariet
diamet
alon
would
detect
case
falseposit
rate
ad
afp
increas
detect
combin
test
ultrasound
bipariet
diamet
afp
free
bhcg
detect
anoth
studi
indic
perinat
death
ntd
use
ultrasound
approach
alon
could
potenti
prevent
use
preconceptu
folat
therefor
new
zealand
new
guidelin
implement
requir
elig
pregnant
women
offer
nuchal
transluc
scan
combin
blood
test
improv
ntd
detect
studi
could
take
sampl
pregnant
women
alreadi
diagnos
ntdaffect
pregnanc
prenat
ultrasound
ultrasound
suffici
enough
ntd
case
think
selditofm
least
serv
addit
method
ntd
pregnanc
detect
rel
high
sensit
specif
pilot
studi
demonstr
applic
seldi
protein
profil
detect
mother
ntdaffect
fetus
preliminarili
establish
rel
specif
procedur
detect
ntdaffect
pregnanc
use
combin
proteinchip
technolog
classif
regress
tree
analysi
conceiv
design
experi
zl
qz
perform
experi
zl
zy
qz
analyz
data
zl
qz
wrote
paper
zl
qz
